Evidence map›Paper›PMID 28361293›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2017

Activation of liver X receptor α protects amyloid β

Bingling Dai, Chunyan Lei, Ru Lin, Lifei Tao, Yue Bin, Hui Peng, Bo Lei

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Involvement of FSP1-CoQCell death & disease · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. The Effect ofInternational journal of molecular sciences · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bingling DaiChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.
Chunyan LeiChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.
Ru LinChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.
Lifei TaoChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.
Yue BinChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.
Hui PengChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China. pengh9@sina.com.
Bo LeiChongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China. bolei99@126.com.
First Affiliated Hospital of Chongqing Medical University · CNChongqing Medical University · CNHenan Provincial Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether activation of the liver X receptors (LXRs) inhibits amyloid β MATERIALS AND

methodsConfluent cultures of human primary RPE and ARPE-19 cells pretreated with 5 μΜ of TO901317 (TO90), a synthetic agonist of LXR, or vehicle were incubated with 1 μΜ of Aβ

resultsA negative linear relationship between the Aβ

conclusionActivation of the LXRα-ABCA1 axis may alleviate Aβ

Indexed as

Amyloid beta-PeptidesBenzenesulfonamidesCell LineCells, CulturedCell SurvivalCellular SenescenceCytokinesEpithelial CellsFluorocarbonsHumansHydrocarbons, FluorinatedInflammationLiver X ReceptorsMacular DegenerationNF-kappa BPeptide FragmentsAmyloid beta-Peptidesamyloid beta-protein (1-40)BenzenesulfonamidesCytokinesFluorocarbonsHydrocarbons, FluorinatedLiver X ReceptorsNF-kappa BNR1H3 protein, humanPeptide FragmentsSulfonamidesT0901317Age-related macular degenerationAmyloidβATP-binding cassette transporter A1Liver X receptorP16INK4aRetinal pigment epithelium

Identifiers

PMID28361293
OpenAlexW2597889117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.